Abstract

Biological sex differences affect the course of HIV infection, with untreated women having lower viral loads compared to their male counterparts but, for a given viral load, women have a higher rate of progression to AIDS. However, the vast majority of data on viral evolution, a process that is clearly impacted by host immunity and could be impacted by sex differences, has been derived from men. We conducted an intensive analysis of HIV-1 gag and env-gp120 evolution taken over the first 6–11 years of infection from 8 Women’s Interagency HIV Study (WIHS) participants who had not received combination antiretroviral therapy (ART). This was compared to similar data previously collected from men, with both groups infected with HIV-1 subtype B. Early virus populations in men and women were generally homogenous with no differences in diversity between sexes. No differences in ensuing nucleotide substitution rates were found between the female and male cohorts studied herein. As previously reported for men, time to peak diversity in env-gp120 in women was positively associated with time to CD4+ cell count below 200 (P = 0.017), and the number of predicted N-linked glycosylation sites generally increased over time, followed by a plateau or decline, with the majority of changes localized to the V1-V2 region. These findings strongly suggest that the sex differences in HIV-1 disease progression attributed to immune system composition and sensitivities are not revealed by, nor do they impact, global patterns of viral evolution, the latter of which proceeds similarly in women and men.

Highlights

  • Previous studies have suggested that biological sex differences exist in the natural history and viral population genetics of HIV-1 infection

  • Our analysis reveals no significant differences in the nucleotide substitution rates between the male and female cohorts we studied with the caveat that these two cohorts had comparable set-point viral load measures

  • The present study reports the comprehensive analysis of HIV evolution in women from around the time of seroconversion until the onset of AIDS or antiretroviral therapy (ART)

Read more

Summary

Introduction

Previous studies have suggested that biological sex differences exist in the natural history and viral population genetics of HIV-1 infection. HIV-1 subtype A and D infected women in Kenya were reported to have a high degree of viral genetic variation early in infection relative to their male counterparts [6]; yet, follow up studies found that upon exclusion of individuals with other sexually transmitted diseases, biological sex did not predispose individuals to the acquisition of multiple variants [7, 8]. T cells in women were found to produce elevated levels of IFN-stimulated genes (ISG) in response to IFN-α compared to male counterparts [13]. These studies suggest that the higher levels of immune activation in women may result in faster HIV-1 disease progression compared to men

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call